1. CURRENT POSITION: Since 01/12/2018 Acting Chair of the Department of Neurology in the SHAARE ZEDEK MEDICAL CENTER, Jerusalem, Israel Secretary of the Israeli Society of Stroke 2. PRIOR PROFFESIONAL POSITONS 1999-2000 Internship at the Hadassah Ein-Kerem Medical Center, Jerusalem 2000-2002 Service in the Medical Core of the IDF 2002-2008 Resident in the Department of Neurology at the Hadassah Ein-Kerem Medical Center, Jerusalem 2008-2009 Medical Scientific Advisor for Clinical Research Development at MERZ Germany 2009-2014 Senior Neurologist and Attending Physician at the Neurological Department of Hadassah Ein-Kerem 2014-2015 Fellowship in ICU (Board for General ICU Dec 2015) 01/2015-03/2016 Head of Neurocritical Care Services at the Hadassah Medical Center 03/2016-01/2019 Director of Stroke Unit and Neurological ICU at the Shaare Zedek Medical Center 01/2019- Chair of the Nurological Department at the Shaare Zedek Medical Center

Gloria is a Stroke Nurse Consultant, She worked at Kings College Hospital, Denmark Hill, London for several years. A UK accredited health trainer and care manager, with a master’s degree in Advanced Neuroscience Practice, Gloria is a neuroscientist with a specialist interest in stroke/TIA care and management. She has over 12 years of nursing practice in the UK. At Imperial College Healthcare NHS Trust she pioneered the Nurse-led fast track TIA assessment and management clinic. More recently Gloria is a board member and a Fellow (FWSO) of World stroke organisation (WSO), person at large for stroke support organisation (SSO). She has been sharing her expertise on stroke management through conferences, seminars, training courses and publications. Gloria is the Chief Executive Officer (CEO) and a representative of Stroke care International United Kingdom and Nigeria.

A/Professor Elif Ekinci is a clinician researcher, an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She does this by undertaking observational studies and clinical trials. She collaborates with basic scientists, engineers, people living with diabetes and other scientists to pave a path forward to translate discoveries into solutions that can change clinical practice. She is the Weary Dunlop Medical Research Foundation Principal Research Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at The University of Melbourne, Department of Medicine, Austin Health. The Dame Kate Campbell Fellowship is given to researchers recognising incredible contributions to the University of Melbourne for outstanding research and wider involvement in our local community and across the globe. She has supervised 7 PhD students to completion and is currently supervising 9 PhD students. She has 176 peer reviewed publications in the leading diabetes, obesity and metabolism journals and has an H index of 31. She has received multiple awards for her work including Australian Diabetes Society Ranji and Amara Wikramanayake Clinical Diabetes Research Award given to the leading early- mid career diabetes researcher in Australia.She has had an accelerated career trajectory in the past five years, having had career disruptions to care for her three young children previously. She is also the Head of Diabetes at Austin Health, where she co-ordinates the clinical care of inpatients and outpatients with diabetes. She heads diabetes and obesity clinical trials at Austin Health at the Centre for Research and Education in Diabetes and Obesity. A/Prof Ekinci is the inaugural director of Australian Centre for Accelerating Diabetes Innovations (ACADI). In 2022, ACADI was established through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect. ACADI has been awarded $10million from the Australian Government’s Medical Research Future Fund and received over $13million in cash and in- kind support from its partners. Led out of the University of Melbourne, ACADI will deliver novel interventions for timely diagnosis, prevention and treatment of diabetes and its complications with the access to clinical evaluation, leadership and networks, research commercialisation experience and workforce training. ACADI's design responds to key barriers slowing Australian development of innovations.